These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
680 related articles for article (PubMed ID: 14583498)
21. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386 [TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Layfield LJ; Willmore C; Tripp S; Jones C; Jensen RL Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):91-6. PubMed ID: 16540738 [TBL] [Abstract][Full Text] [Related]
23. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study. Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203 [TBL] [Abstract][Full Text] [Related]
24. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme. Stockhausen MT; Broholm H; Villingshøj M; Kirchhoff M; Gerdes T; Kristoffersen K; Kosteljanetz M; Spang-Thomsen M; Poulsen HS Exp Cell Res; 2011 Jul; 317(11):1513-26. PubMed ID: 21514294 [TBL] [Abstract][Full Text] [Related]
25. Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Ionescu DN; Sasatomi E; Cieply K; Nola M; Dacic S Cancer; 2005 Feb; 103(3):630-6. PubMed ID: 15630697 [TBL] [Abstract][Full Text] [Related]
26. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Cho EY; Choi YL; Han JJ; Kim KM; Oh YL Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636 [TBL] [Abstract][Full Text] [Related]
27. Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas. Saito T; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Arifin MT; Arita K; Kurisu K Anticancer Res; 2006; 26(2B):1351-7. PubMed ID: 16619544 [TBL] [Abstract][Full Text] [Related]
28. The natural history of EGFR and EGFRvIII in glioblastoma patients. Heimberger AB; Suki D; Yang D; Shi W; Aldape K J Transl Med; 2005 Oct; 3():38. PubMed ID: 16236164 [TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446 [TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood. Bredel M; Pollack IF; Hamilton RL; James CD Clin Cancer Res; 1999 Jul; 5(7):1786-92. PubMed ID: 10430083 [TBL] [Abstract][Full Text] [Related]
31. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Pandita A; Aldape KD; Zadeh G; Guha A; James CD Genes Chromosomes Cancer; 2004 Jan; 39(1):29-36. PubMed ID: 14603439 [TBL] [Abstract][Full Text] [Related]
32. EGFR gene and protein expression in breast cancers. Park K; Han S; Shin E; Kim HJ; Kim JY Eur J Surg Oncol; 2007 Oct; 33(8):956-60. PubMed ID: 17374474 [TBL] [Abstract][Full Text] [Related]
33. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678 [TBL] [Abstract][Full Text] [Related]
34. Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer. Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Ogawa J Anticancer Res; 2005; 25(6C):4693-8. PubMed ID: 16334162 [TBL] [Abstract][Full Text] [Related]
35. EGFRvIII mutation in lung cancer correlates with increased EGFR copy number. Sasaki H; Kawano O; Endo K; Yukiue H; Yano M; Fujii Y Oncol Rep; 2007 Feb; 17(2):319-23. PubMed ID: 17203167 [TBL] [Abstract][Full Text] [Related]
36. Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer. Tsutsui S; Kataoka A; Ohno S; Murakami S; Kinoshita J; Hachitanda Y Clin Cancer Res; 2002 Nov; 8(11):3454-60. PubMed ID: 12429634 [TBL] [Abstract][Full Text] [Related]
37. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis. Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238 [TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer. Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466 [TBL] [Abstract][Full Text] [Related]
40. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung. Kim YT; Kim TY; Lee DS; Park SJ; Park JY; Seo SJ; Choi HS; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH Lung Cancer; 2008 Jan; 59(1):111-8. PubMed ID: 17904685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]